08 8267 5547


Specialist Neurologist & Nuclear Physician - MBBS FRACP

Dr Reynolds ‘Rey’ Casse is a consultant neurologist and nuclear physician. He obtained a Bachelor of Medicine and Surgery at the University of Adelaide in 1987. He obtained his Neurology fellowship in 1997. He undertook nuclear medicine training at the Austin Repatriation Hospital in Melbourne and The Queen Elizabeth Hospital in Adelaide.

Dr Casse also undertook a movement disorders fellowship at Westmead Hospital, Sydney in 1997. He further completed an Epilepsy fellowship at the Austin Repatriation Hospital, Melbourne in 1998.

From 2001 to present he is one of the only Clinical Neurologist’s admitting to Memorial and Calvary Adelaide Hospital in South Australia. He is also a staff specialist at the Queen Elizabeth Hospital in the Nuclear Medicine Department.

Dr Casse has over two decades of clinical research and experience. He has devoted his career to providing rigorous, comprehensive and compassionate care to his patients and had a clinical subspecialty in headache and injection therapy for chronic migraine.

Dr Casse’s clinical practice offers a comprehensive headache service. These conditions, which include migraine, cluster headache, and post traumatic headache, are disabling, often stigmatized and poorly understood. It is becoming increasingly clear that these disorders are not ‘just headaches’, but complex disruptions of brain excitability and homeostasis.

Dr Rey Casse is a Neurologist and the Director of Migraine Specialist Centre in North Adelaide. The clinic is the largest dedicated headache clinic in South Australia, and specialises in the treatment of chronic migraines, including the provision of botulinum toxin therapy and monoclonal antibodies. Dr Casse is also member of the Australian and New Zealand Association of Neurologists (ANZAN), as well as the Treasurer of the Australian and New Zealand Headache Society (ANZHS).

Dr Casse also has a special interest in Seizure Disorders. This forms part of our practice ‘Adelaide NeuroDiagnostics’.